Toru Yoshiura | Clinical Neuroscience | Neuroscience Research Excellence Award

Dr. Toru Yoshiura | Clinical Neuroscience | Neuroscience Research Excellence Award

Dr. Toru Yoshiura,  National Defense Medical College, Japan.

Dr. Toru Yoshiura, a Lieutenant Commander in the Japan Maritime Self-Defense Force (JMSDF) and a board-certified neurosurgeon, has cultivated a remarkable career blending military service, clinical excellence, and academic research. A graduate of the National Defense Medical College, he has pursued specialized training in diving medicine and neuroendoscopic surgery while serving in key clinical and field deployments, including anti-piracy missions. His research focuses on innovative neuroprotective strategies for subarachnoid hemorrhage, and he actively contributes to the education of future neurosurgeons through specialized anatomical dissection courses. Dr. Yoshiura holds multiple national certifications and is an active member of prominent neurosurgical societies, where he plays a leadership role in advancing young professionals.

Profile

Orcid

🎓 Early Academic Pursuits

Born on January 15, 1987, in Hiroshima, Japan, Dr. Toru Yoshiura began his distinguished journey in medicine with a solid academic foundation at the National Defense Medical College, where he pursued his studies from April 2005 to March 2011. During these formative years, he developed a strong inclination toward the intricate world of neurosurgery. His academic journey was not limited to conventional study; he also completed rigorous military medical training at the JMSDF Officer Candidate School in 2011 and the Diving Medical Officer’s Course in 2013. Driven by both curiosity and commitment, Dr. Yoshiura later pursued graduate studies in medicine at the same institution, where he currently investigates novel therapeutic strategies in neurosurgical conditions, particularly focusing on cerebral ischemia models.

⚓ Professional Endeavors

Dr. Yoshiura’s career seamlessly blends clinical excellence with military service. Since 2011, he has been a commissioned officer in the Japan Maritime Self-Defense Force (JMSDF), rising to the rank of Lieutenant Commander. His professional journey commenced with a clinical residency at the National Defense Medical College Hospital, followed by a tenure as a neurosurgeon at JSDF Yokosuka Hospital, where he also took part in the 17th Deployment Surface Force Counter Piracy Enforcement in 2013–2014. Subsequent assignments included advanced clinical residency, service at the JSDF Central Hospital, and another deployment during the 37th Counter Piracy Enforcement (2020–2021). Currently, he practices at the National Defense Medical College Hospital, where he brings both his clinical and research expertise to the forefront.

🧠 Contributions and Research Focus

Dr. Yoshiura has emerged as a dedicated researcher with a keen interest in neuroprotection and neurovascular recovery. His ongoing doctoral research explores the synergistic effects of hydrogen inhalation and intrathecal magnesium sulfate treatment in enhancing ischemic outcomes without suppressing cortical spreading depolarization—work that promises to revolutionize the management of subarachnoid hemorrhage (SAH). Moreover, he serves as the Course Director of the White Matter Dissection Course, a specialized program aimed at enhancing neurosurgical anatomical understanding, further showcasing his commitment to academic mentorship and the future of neurosurgical training.

🏅 Accolades and Recognition

Dr. Yoshiura’s dedication to excellence has been officially recognized through multiple prestigious medical certifications in Japan. He holds certifications from the Japanese Boards of Neurosurgery, Stroke, Neuroendovascular Therapy, and Neurotraumatology, and he is also a qualified Neuroendoscopic Surgeon. His credentials reflect a consistent track record of advanced surgical training and expertise across a spectrum of subspecialties, reinforcing his status as a versatile and trusted neurosurgeon in both military and civilian healthcare settings.

🌐 Impact and Influence

Beyond operating rooms and laboratories, Dr. Yoshiura has made meaningful contributions to the broader medical and scientific community through active engagement with multiple professional organizations. He is a core member of the Under 40 Committee of the Japanese Congress for Brain Tumor Surgery, signifying his leadership among emerging neurosurgeons. His involvement spans a wide array of societies, including the Japan Neurosurgical Society, Japanese Society on Surgery for Cerebral Stroke, and Japan Society for Neuro-Oncology, among others. This multi-society participation not only amplifies his influence but also allows him to remain at the cutting edge of developments in neurosurgical practice and policy.

🌍 Service Beyond Borders

Dr. Yoshiura’s compassion and sense of duty extend beyond his professional obligations. In 2010, he volunteered at a kindergarten in Bari, Indonesia, demonstrating his humanitarian spirit and willingness to serve communities in need. This formative experience abroad may have enriched his global outlook on medicine and underscored the human side of healthcare—a trait that continues to inform his interactions with patients and peers alike.

🚀 Legacy and Future Contributions

As a rising leader in neurosurgery within the military-medical sphere, Dr. Yoshiura’s legacy is already being defined by a synthesis of cutting-edge research, exceptional surgical practice, and dedicated mentorship. With his ongoing doctoral work poised to make significant contributions to the treatment of ischemic brain injuries, and his involvement in advanced neurosurgical education, he is set to influence both clinical practices and the next generation of neurosurgeons. His unique integration of military precision and academic rigor ensures that his future contributions will be both impactful and enduring.

Publication

  1. Title: Carotid Endarterectomy with Twisted Internal Jugular Vein Located Anterior to the Common Carotid Artery
    Authors: Arumu Endo, Terushige Toyooka, Kazuya Fujii, Satoru Takeuchi, Toru Yoshiura, Masaya Nakagawa, Yohei Otsuka, Arata Tomiyama, Kojiro Wada
    Year: 2025

 

  1. Title: Effectiveness of Keyhole Clipping of Unruptured Intracranial Aneurysms Detected by “Brain Dock” in Healthy Japanese Adults
    Authors: Toru Yoshiura, Satoru Takeuchi, Terushige Toyooka, Arata Tomiyama, Kojiro Wada, Yasuaki Nakao, Takuji Yamamoto, Kentaro Mori, toruyukiko
    Year: 2023

 

  1. Title: KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway
    Authors: Takashi Fujii, Yoshiko Nakano, Daichi Hagita, Nobuyuki Onishi, Arumu Endo, Masaya Nakagawa, Toru Yoshiura, Yohei Otsuka, Satoru Takeuchi, Mario Suzuki et al.
    Year: 2023

 

  1. Title: Surgical Rescue Technique for Incomplete Burr Hole Using a Small Bone Piece and the Craniotome
    Authors: Toru Yoshiura, Kojiro Wada, Kosuke Kumagai, Satoru Takeuchi, Terushige Toyooka, Otani, Kentaro Mori
    Year: 2019

🔚 Conclusion

Dr. Yoshiura’s journey exemplifies a rare integration of surgical mastery, military discipline, and scientific innovation. His commitment to advancing the field of neurosurgery—through both cutting-edge research and hands-on mentorship—positions him as a future leader in academic and military medicine alike. With a career rooted in service, science, and skill, Dr. Yoshiura is not only shaping current practices but also building a lasting legacy for future generations of neurosurgeons in Japan and beyond.

Dongfeng Zeng | hematology | Excellence in Research

Prof. Dr. Dongfeng Zeng | hematology | Excellence in Research

Prof. Dr.  Dongfeng Zeng,  Daping Hospital, Third Military Medical University (Army Medical University), China.

Dr. Zeng Dongfeng’s career is a testament to his dedication to hematology, patient care, and research. From his early academic pursuits to his professional achievements, he has consistently demonstrated excellence in the field. His research contributions in hematopoietic stem cell transplantation, G-CSF preconditioning, and immunotherapy for blood disorders have paved the way for innovative treatments. His recognition as a distinguished scholar and his mentorship of aspiring medical professionals further cement his impact on the medical community.

Profile

Scopus

🎓 Early Academic Pursuits

From the very beginning of his academic journey, Dr. Zeng Dongfeng exhibited an unwavering dedication to the field of medicine. His passion for understanding the complexities of hematology led him to earn a Doctor of Medicine degree, where he developed a deep-rooted expertise in treating blood disorders. His educational foundation was instrumental in shaping his approach to clinical research, patient care, and medical innovations. With rigorous training and an insatiable curiosity, Dr. Zeng embarked on a path that would position him as a key figure in hematological advancements.

🏋️‍♂️ Professional Endeavors

Dr. Zeng’s career commenced at Xinqiao Hospital, where he served as an attending physician and lecturer in the Department of Hematology. His expertise and leadership skills quickly became evident, leading him to take on significant roles in various prestigious institutions. His tenure at the Tibet Military Region General Hospital provided him with a unique perspective on treating patients in diverse and challenging environments. Further strengthening his credentials, he pursued postdoctoral research at the Institute of Combined Injury at the Third Military Medical University. His career continued to flourish as he assumed responsibilities as an associate chief physician, associate professor, and deputy director at the Army Specialty Medical Center.

🔬 Contributions and Research Focus

Throughout his career, Dr. Zeng has focused on cutting-edge research aimed at revolutionizing the treatment of hematological disorders. His studies on hematopoietic stem cell transplantation for pediatric hematologic malignancies laid the groundwork for improved therapeutic strategies. His extensive research on G-CSF pre-stimulation and preconditioning regimens for MRC-AML has contributed to advancements in transplantation techniques. Additionally, his work on sequential low-dose decitabine therapy for elderly MDS patients has provided new hope for those struggling with myelodysplastic syndromes. Dr. Zeng’s involvement in monitoring the effects of sintilimab injection and evaluating novel therapies such as Ociperlimab in combination with chemotherapy for metastatic non-small cell lung cancer underscores his commitment to pioneering transformative treatments in the medical field.

🏆 Accolades and Recognition

Dr. Zeng’s expertise and contributions have earned him widespread recognition in the medical community. His role as a visiting scholar at the MD Anderson Cancer Center in the United States provided him with international exposure and the opportunity to collaborate with global leaders in oncology and hematology. His reputation as a dedicated clinician, researcher, and mentor has solidified his status as a respected figure in his field. Through his continuous efforts in advancing hematological research, he has become a beacon of excellence, inspiring future generations of medical professionals.

📚 Impact and Influence

Beyond his clinical and research contributions, Dr. Zeng has profoundly impacted the medical field through his mentorship and guidance. By leading innovative studies, he has not only shaped the direction of hematology but also influenced young researchers and physicians who aspire to follow in his footsteps. His work has played a pivotal role in improving patient outcomes and developing new standards of care, proving that his influence extends far beyond the walls of his medical institution. His collaborations with international researchers have further expanded the scope of hematological treatments and their applicability in real-world scenarios.

🌟 Legacy and Future Contributions

As a visionary in hematology, Dr. Zeng Dongfeng continues to push the boundaries of medical research and patient care. His ongoing studies on hepatitis B reactivation prevention in CD20-positive B-cell lymphoma patients and immunotherapy applications in metastatic lung cancer demonstrate his relentless pursuit of medical breakthroughs. His legacy is not only built on the achievements of the past but also on the promise of future innovations. With each clinical trial and research endeavor, Dr. Zeng is shaping the future of hematology, leaving behind a lasting impact that will benefit generations to come.

Publication

  • Title: Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis
    Author: F. Meng, M. Xiang, Y. Liu, D. Zeng
    Year: 2024

 

  • Title: IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
    Author: H. Xie, J. Zhang, R. Luo, X. Li, D. Zeng
    Year: 2024

 

  • Title: Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma
    Author: J. Feng, Y. Fei, M. Gao, X. Wang, H. Zhang
    Year: 2024

 

  • Title: Supplementing Glucose Intake Reverses the Inflammation Induced by a High-Fat Diet by Increasing the Expression of Siglec-E Ligands on Erythrocytes
    Author: H. Liu, J. Li, N. Wu, D. Zeng, Y. Jia
    Year: 2024

 

  • Title: Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes
    Author: C. Luo, X. Li, B. Yan, X. Wu, S. Xu
    Year: 2024

 

  • Title: Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE
    Author: D. Zeng, Y. Fang, Y. Fei, D. Zou, Q. Cai
    Year: 2023

 

  • Title: ARHGAP4 promotes leukemogenesis in acute myeloid leukemia by inhibiting DRAM1 signaling
    Author: Y. Qi, M. Hu, C. Han, J. Wang, D. Zeng
    Year: 2023

 

💡 Conclusion

Dr. Zeng Dongfeng’s journey in hematology is a reflection of his passion, perseverance, and commitment to advancing medical science. His groundbreaking research and clinical expertise have significantly improved treatment options for patients with hematological disorders. As he continues his pursuit of scientific discoveries and patient-centered innovations, his contributions will undoubtedly shape the future of hematology and inspire future generations of medical professionals worldwide. His legacy stands as a guiding light for those who seek to make a meaningful difference in the field of medicine.